Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failure.
AUTHORS
Self
WH ,
Storrow
AB ,
Hartmann
O ,
Barrett
TW ,
Fermann
GJ ,
Maisel
AS ,
Struck
J ,
Bergmann
A ,
Collins
SP ,
. The American journal of emergency medicine. 2015 10 24; ().
- PMID: 26577429 [PubMed].
ABSTRACT
The objective was to evaluate the prognostic performance of a new biomarker, plasma bioactive adrenomedullin (bio-ADM), for short-term clinical outcomes in acute heart failure.
The objective was to evaluate the prognostic performance of a new biomarker, plasma bioactive adrenomedullin (bio-ADM), for short-term clinical outcomes in acute heart failure.
Tags: Alumni Publications 2015